Reliq Health Technologies Inc. (CVE:RHT), a health tech stock, moved up after announcing the go-live of its remote patient monitoring and telemedicine solution with Paz Home Health LLC
Sean Mason | August 1, 2017 | SmallCapPower
An expected surge in recurring revenue was a dose of good news for investors in a health tech stock Tuesday. Here’s some small stocks making big moves on Tuesday, August 1, 2017 (as of 4 pm EST):
Reliq Health Technologies Inc. (TSXV: RHT), a health tech stock, jumped 14% to $0.125 on Tuesday after announcing the go-live of its remote patient monitoring and telemedicine solution with Paz Home Health LLC in Texas. The Company expects to add more than 500 Paz Home Health patients to the platform each month going forward, generating over $6 million in recurring annual revenue at full deployment.
As well, shares of Guyana Goldfields Inc. (TSX: GUY) slipped 15% to $4.10 as the gold miner said it expects 2017 production to come in at the lower end of the guidance range of 160,000 to 180,000 ounces of gold.
International Barrier Technology Inc. (TSXV: IBH), meanwhile, reported that it has agreed to be acquired by Louisiana-Pacific Corporation for US$0.41 per common share in cash, or a total purchase price of US$22 million. International Barrier Technology stock popped 60% to $0.495 following the announcement.
Hi, did you know SmallCapPower accepts blog submissions? You can contact me here
Disclosure: Neither the author nor any of the principals at Small Cap Power, or their family members, own shares in any of the companies mentioned above.
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.
